| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.IJPHARM.2011.08.032 |
| P698 | PubMed publication ID | 21884771 |
| P2093 | author name string | Satomi Onoue | |
| Shizuo Yamada | |||
| Yohei Kawabata | |||
| Koichi Wada | |||
| Manabu Nakatani | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2011-08-30 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications | |
| P478 | volume | 420 |
| Q91867722 | 1H NMR Relaxation Study to Evaluate the Crystalline State of Active Pharmaceutical Ingredients Containing Solid Dosage Forms Using Time Domain NMR |
| Q55717191 | A Miniaturized Extruder to Prototype Amorphous Solid Dispersions: Selection of Plasticizers for Hot Melt Extrusion. |
| Q58700186 | A Novel Protocol Using Small-Scale Spray-Drying for the Efficient Screening of Solid Dispersions in Early Drug Development and Formulation, as a Straight Pathway from Screening to Manufacturing Stages |
| Q98614953 | A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive? |
| Q43893051 | A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid |
| Q45836862 | A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib |
| Q38243872 | A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms. |
| Q57377103 | Acceleration of the crystal growth rate of low molecular weight organic compounds in supercooled liquids in the presence of polyhydroxybutyrate |
| Q53502218 | Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability. |
| Q36710243 | Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption |
| Q38573658 | Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications |
| Q36318232 | An optimized molecular inclusion complex of diferuloylmethane: enhanced physical properties and biological activity |
| Q38243777 | An overview on in situ micronization technique - An emerging novel concept in advanced drug delivery |
| Q51074380 | Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal. |
| Q38760000 | Automated Supersaturation Stability Assay to Differentiate Poorly Soluble Compounds in Drug Discovery |
| Q38573948 | Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review |
| Q57376932 | Chiral discrimination by a cellulose polymer: differential crystallization inhibition of enantiomers in amorphous dispersions |
| Q39172749 | Clinical pharmacokinetics of an amorphous solid dispersion tablet of elacridar |
| Q35219316 | Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug |
| Q42366838 | Comparative Pharmacokinetic Study for Linezolid and Two Novel Antibacterial Oxazolidinone Derivatives in Rabbits: Can Differences in the Pharmacokinetic Properties Explain the Discrepancies between Their In Vivo and In Vitro Antibacterial Activities |
| Q91812245 | Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance |
| Q36307613 | Controlled Drug Delivery: Historical perspective for the next generation |
| Q50442842 | Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs |
| Q53528770 | Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin. |
| Q51671101 | Crystallization of undercooled liquid fenofibrate. |
| Q91705523 | Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation |
| Q41124333 | Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits. |
| Q53076511 | Dexibuprofen nanocrystals with improved therapeutic performance: fabrication, characterization, in silico modeling, and in vivo evaluation. |
| Q91907038 | Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability |
| Q53259496 | Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers. |
| Q45860815 | Does the Digestibility of Cyclodextrins Influence the In Vivo Absorption of Benzo[a]pyrene in Rats? |
| Q58550048 | Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction |
| Q64250399 | Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion |
| Q51750452 | Effect of ball milling on the physicochemical properties of atorvastatin calcium sesquihydrate: the dissolution kinetic behaviours of milled amorphous solids. |
| Q42593696 | Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation |
| Q92136757 | Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion. II: Rheological Analysis and Extrudability Testing |
| Q40261316 | Encapsulation and Delivery of Crystalline Hydrophobic Nutraceuticals using Nanoemulsions: Factors Affecting Polymethoxyflavone Solubility. |
| Q57174036 | Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium |
| Q39574444 | Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. |
| Q50799182 | Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. |
| Q59796430 | Enzymatic synthesis of α-flavone glucoside via regioselective transglucosylation by amylosucrase from Deinococcus geothermalis |
| Q54440180 | Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane. |
| Q57345919 | Excipients That Facilitate Amorphous Drug Stabilization |
| Q49957833 | Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity |
| Q57166899 | Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector |
| Q91271768 | Fabrication of Hierarchical Polymeric Thin Films by Spin Coating Toward Production of Amorphous Solid Dispersion for Buccal Drug Delivery System: Preparation, Characterization, and In Vitro Release Investigations |
| Q64072216 | Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability |
| Q41497081 | Formulation and Characterization of Solid Dispersion Prepared by Hot Melt Mixing: A Fast Screening Approach for Polymer Selection |
| Q92384280 | Formulation and Pharmacokinetic Evaluation of Phosal Based Zaltoprofen Solid Self-Nanoemulsifying Drug Delivery System |
| Q41564434 | Formulation and Solid State Characterization of Nicotinamide-based Co-crystals of Fenofibrate |
| Q38916539 | From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). |
| Q33766568 | High drug-loading nanomedicines: progress, current status, and prospects |
| Q58073593 | High-throughput nanoprecipitation of the organic antimicrobial triclosan and enhancement of activity against Escherichia coli |
| Q57340445 | Hot Melt Extrusion: A Process Overview and Use in Manufacturing Solid Dispersions of Poorly Water-Soluble Drugs |
| Q42433654 | Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine |
| Q35586493 | Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs |
| Q92204639 | Identifying, Characterizing, and Understanding Nefiracetam in Its Solid State Forms: A Potential Antidementia Drug |
| Q53185280 | Impact of HPMC on the physical properties of spray-congealed PEG microparticles and its swelling effect on rifampicin dissolution. |
| Q36107736 | Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique |
| Q47210498 | Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer |
| Q60948280 | In vitro antiplasmodial activity, pharmacokinetic profiles and interference in isoprenoid pathway of 2-aniline-3-hydroxy-1.4-naphthoquinone derivatives |
| Q47719879 | Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole |
| Q37155004 | Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. |
| Q89909966 | Influence of solvent mixtures on HPMCAS-celecoxib microparticles prepared by electrospraying |
| Q47787434 | Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development |
| Q91676507 | Kinetics Study of Cocrystal Formation Between Indomethacin and Saccharin Using High-Shear Granulation With In Situ Raman Spectroscopy |
| Q38939373 | Layer-by-Layer Coating of Solid Drug Cores: A Versatile Method to Improve Stability, Control Release and Tune Surface Properties |
| Q48034195 | Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. |
| Q91810805 | Liquisolid pellets: A pharmaceutical technology strategy to improve the dissolution rate of ritonavir |
| Q51737696 | Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan. |
| Q47675012 | Metabolic pathways and pharmacokinetics of natural medicines with low permeability |
| Q38182718 | Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility |
| Q55165941 | Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration. |
| Q40375864 | Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin. |
| Q51792669 | NANOPARTICLES. Production of amorphous nanoparticles by supersonic spray-drying with a microfluidic nebulator. |
| Q41810733 | NanoClusters surface area allows nanoparticle dissolution with microparticle properties |
| Q38193067 | Nanodrugs: pharmacokinetics and safety |
| Q38687039 | Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles. |
| Q90468162 | Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics |
| Q59113220 | Nanosuspension Technologies for Delivery of Poorly Soluble Drugs |
| Q41987423 | Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability |
| Q92506035 | Natural Deep Eutectic Solvents as Agents for Improving Solubility, Stability and Delivery of Curcumin |
| Q41871280 | Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. |
| Q38583850 | Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems. |
| Q46849104 | Novel oleic acid derivatives enhance buccal permeation of didanosine |
| Q61810479 | Optimization of the Factors Affecting the Absorption of Vardenafil from Oral Disintegrating Tablets: A Clinical Pharmacokinetic Investigation |
| Q64077472 | Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs |
| Q59811137 | Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells |
| Q38717322 | Poloxamer-Based Thermoreversible Gel for Topical Delivery of Emodin: Influence of P407 and P188 on Solubility of Emodin and Its Application in Cellular Activity Screening |
| Q47898757 | Polymer/Amorphous Salt Solid Dispersions of Ciprofloxacin |
| Q91165485 | Polymeric Nanocarriers With Mucus-Diffusive and Mucus-Adhesive Properties to Control Pharmacokinetic Behavior of Orally Dosed Cyclosporine A |
| Q59016596 | Polymeric Nanosuspensions for Enhanced Dissolution of Water Insoluble Drugs |
| Q37141404 | Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs |
| Q26779030 | Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs |
| Q89261152 | Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs |
| Q102150751 | Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents |
| Q41990616 | Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention |
| Q42788207 | Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability |
| Q34413196 | Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan |
| Q33706563 | Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes |
| Q48244592 | Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory |
| Q61799971 | Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations |
| Q51015806 | Real-Time Visualization of the Precipitation and Phase Behavior of Octaethylporphyrin in Lipid Microparticles. |
| Q38132471 | Recent advancements in mechanical reduction methods: particulate systems |
| Q26801043 | Role of Components in the Formation of Self-microemulsifying Drug Delivery Systems |
| Q60957325 | SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene: Lamellarity and Drug-Loading as Key Features for a Rational Drug Delivery Design |
| Q38175527 | Selecting oral bioavailability enhancing formulations during drug discovery and development. |
| Q47113494 | Self-microemulsifying drug delivery system and nanoemulsion for enhancing aqueous miscibility of Alpinia galanga oil. |
| Q91678104 | Simultaneous Analysis of Dissolution and Permeation Profiles of Nanosized and Microsized Formulations of Indomethacin Using the In Vitro Dissolution Absorption System 2 |
| Q51020710 | Solubility and dissolution enhancement strategies: current understanding and recent trends. |
| Q90310800 | Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs |
| Q53670837 | Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies. |
| Q40167348 | Stable amorphous binary systems of glipizide and atorvastatin powders with enhanced dissolution profiles: formulation and characterization |
| Q57354736 | Star-shaped self-assembled micelles of block copolymer [chitosan-co-poly(ethylene glycol) methyl ether methacrylate] hydrogel for hydrophobic drug delivery |
| Q93238426 | State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation |
| Q57164998 | Sticking and Picking in Pharmaceutical Tablet Compression: An IQ Consortium Review |
| Q38301993 | Strategies for oral delivery and mitochondrial targeting of CoQ10. |
| Q92257789 | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
| Q38883455 | Support Tools in Formulation Development for Poorly Soluble Drugs |
| Q26777831 | Supramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble Drugs |
| Q41547567 | Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine |
| Q90216420 | Synthesis, Characterization, and Pharmacodynamics Study of Enrofloxacin Mesylate |
| Q47696771 | Synthesis, structure, antioxidant activity, and water solubility of trolox ion conjugates. |
| Q52584045 | Tacrolimus Loaded PEG-Cholecalciferol Based Micelles for Treatment of Ocular Inflammation. |
| Q92731084 | The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range |
| Q38644728 | The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations. |
| Q61950864 | The Role of Particle Size in Drug Release and Absorption |
| Q64077469 | The Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent Methods |
| Q42936252 | The influence of pressure on the intrinsic dissolution rate of amorphous indomethacin |
| Q50959135 | The microfluidic nebulator: production of sub-micrometer sized airborne drops. |
| Q38777505 | Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems. |
| Q55470825 | ZnO Nanostructures for Drug Delivery and Theranostic Applications. |
Search more.